The only thing objective about one of my previous
posts regarding BTGC getting back to 16 is that I
bought it along with the rest of the herd baack about 2
years ago. I bought this stock prior to that strictly
based on Fidelity S&P Newsletters recommending BTGC.
Bought 3000 shrs at $7 Shr and within 3 - 6 months had a
double. SOld and then bought back in at 16 1/4 which I
thought was going to be a dip. Well, it's turned out to
be a 2 1/2 year dip - thanks to this new drug test
not doing great.
I keep watching my Fidelity
newsletters, haven't continued coverage yet, but stay tuned.